about
Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the LiteratureA critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths.Need and utility of a polyethylene glycol marker to ensure against urine falsification among heroin usersPolydrug abuse: a review of opioid and benzodiazepine combination useMethadone induction doses: are our current practices safe?Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention.The Impact of Opioids on Cardiac Electrophysiology.Methadone death, dosage and torsade de pointes: risk-benefit policy implications.Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.Interim buprenorphine treatment in opiate dependence: A pilot effectiveness study.Opioid substitution treatment is linked to reduced risk of death in opioid use disorder.A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia.Intravenous methadone application as a serious risk factor for an overdose death: methadone-related fatalities in Hamburg from 2007 to 2012.Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).Fast gas chromatography/mass spectrometric assay for the validated quantitative determination of methadone and the primary metabolite EDDP in whole blood.Use of illegally acquired medical opioids by opiate-dependent patients in detoxification treatment.Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings.Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users.
P2860
Q26785445-1AACD0EA-2D2C-4F7D-8729-50AEF1BC288EQ35841618-10861DB6-21E1-4B89-8BDC-70C2F4480A19Q35875443-9EE07F9B-50B7-4749-B08F-ACD173D0CDCEQ36266246-6508DE19-79BA-4D30-AB53-287517FE1B2BQ36587144-1D7D36AB-BD6F-4D07-A8E1-BE084F28DB11Q36629372-2CE62A05-A03B-4C81-BDF4-A8E70285B5F8Q36728665-FD966EA3-408B-46F0-921A-F7F272E3F0EBQ36764780-55C444B3-1FED-4EF8-BA8A-573710ECDE84Q36811537-1886A444-89A9-4519-9420-2B1E2D983A13Q37801439-5C0679E5-4CB5-4C9D-95B6-7861128DDEA2Q38473638-45CD0B34-2A7B-470A-901E-C88D01F438D3Q40132985-60E591C3-6629-4FE3-ACCF-F6CA3A7C8932Q40734797-3AE916D3-42C5-43FE-9C6A-76184AC5DAF5Q42356502-CACCCFFD-E523-4C72-8DB6-2F4FA2CDF0A5Q43290722-2C5DBEA5-CF3A-4C5E-9C95-BB7B13C83846Q43660554-0FC66F8B-0277-491F-99CA-13A56D91FACBQ44344971-E339315E-5DC6-4532-B4FD-35EDE0D97ECBQ46919738-558F7FD8-7DCC-4598-B4B9-ADB926009FF6Q48477480-5552D1C2-984D-4BBF-8644-262FA4CDAE03Q50775098-2B78A86E-6528-4D8A-9DA5-5080EFFC295EQ51914439-2835A16C-4D34-4A3F-ABBD-7D8F634FDC04
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Death attributed to methadone.
@ast
Death attributed to methadone.
@en
Death attributed to methadone.
@nl
type
label
Death attributed to methadone.
@ast
Death attributed to methadone.
@en
Death attributed to methadone.
@nl
prefLabel
Death attributed to methadone.
@ast
Death attributed to methadone.
@en
Death attributed to methadone.
@nl
P356
P1433
P1476
Death attributed to methadone.
@en
P2093
P304
P356
10.1055/S-2001-18032
P577
2001-11-01T00:00:00Z